期刊
JOURNAL OF MEDICAL VIROLOGY
卷 94, 期 10, 页码 5044-5050出版社
WILEY
DOI: 10.1002/jmv.27934
关键词
cohort studies; COVID-19; COVID-19 vaccines; immunogenicity; pandemic; SARS-CoV-2; vaccination; vaccine effectiveness
类别
A study in Greece found that all vaccines currently in use, including BNT162b2, mRNA-1273, and ChAdOx1 nCov-19, have a very high effectiveness against severe disease and death from COVID-19, with Ad26.COV2.S having slightly lower effectiveness. The effectiveness of the vaccines decreases over time but remains above 80% at 6 months, and three doses increase effectiveness to nearly 100%. Vaccination prevented nearly 20,000 COVID-19 deaths during the study period.
As national coronavirus disease 2019 (COVID-19) mass vaccination campaigns are rolled out, monitoring real-world Vaccine Effectiveness (VE) and its durability is essential. We aimed to estimate COVID-19 VE against severe disease and death in the Greek population, for all vaccines currently in use. Nationwide active surveillance and vaccination registry data during January-December 2021 were used to estimate VE via quasi-Poisson regression, adjusted for age and calendar time. Interaction terms were included to assess VE by age group, against the delta severe acute respiratory syndrome coronavirus 2 variant and waning of VE over time. Two doses of BNT162b2, mRNA-1273, or ChAdOx1 nCov-19 vaccines offered very high (>90%) VE against both intubation and death across all age groups, similar against both delta and previous variants, with one-dose Ad26.COV2.S slightly lower. VE waned over time but remained >80% at 6 months, and three doses increased VE again to near 100%. Vaccination prevented an estimated 19 691 COVID-19 deaths (95% confidence interval: 18 890-20 788) over the study period. All approved vaccines offer strong and also durable protection against COVID-19 severe disease and death. Every effort should be made to vaccinate the population with at least two doses, to reduce the mortality and morbidity impact of the pandemic.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据